Atricure to participate in the 2025 wells fargo healthcare conference

Mason, ohio--(business wire)--atricure, inc. (nasdaq: atrc), a leading innovator in surgical treatments and therapies for atrial fibrillation (afib), left atrial appendage (laa) management, and post-operative pain management, today announced that the company will be participating in the upcoming 2025 wells fargo healthcare conference. atricure's management is scheduled to participate in a fireside chat on wednesday, september 3, 2025, at 3:45 p.m. eastern standard time. interested parties may a.
ATRC Ratings Summary
ATRC Quant Ranking